#USA #Chicago #Pharma Services #David Johnston #Water Street

Water Street Healthcare Partners Welcomes David Johnston

In a significant move aimed at bolstering its offerings in the biopharmaceutical sector, Water Street Healthcare Partners has welcomed David M. Johnston, Ph.D., to its esteemed team. A seasoned veteran of the industry, Dr. Johnston's expertise stems from his notable career with Thermo Fisher Scientific, where he played a pivotal role in leading the company's contract research organization, PPD.

A Vision for Impactful Change

Dr. Johnston's appointment reflects Water Street's commitment to enhancing its capabilities in pharmaceutical services and life sciences. In his own words, he expressed excitement about joining Water Street, emphasizing the importance of improving patient care through innovative business strategies. The biopharmaceutical landscape is currently witnessing a transformative phase, characterized by the advent of novel therapeutic approaches and digital technologies. He believes that Water Street is exceptionally positioned to leverage these trends and navigate the complexities of the healthcare regulatory environment for the benefit of growth-oriented businesses.

An Extensive Background

Bringing over 25 years of leadership experience in clinical research to the table, Dr. Johnston has been instrumental in establishing PPD as a frontrunner in supporting complex studies and the development of innovative therapies. His previous roles have seen him guide various global clinical development initiatives, significantly impacting drug and device commercialization. Dr. Johnston's journey commenced at LabCorp, where he rose to the position of senior vice president and global head of clinical trials. His accomplishments include the development of the industry’s first companion diagnostic test, effectively marrying diagnostic capability with therapeutic development.

Water Street's Strategic Growth

The addition of Dr. Johnston comes as Water Street continues to strengthen its footprint in the pharmaceutical and life sciences sectors. The firm boasts an impressive track record, having completed over 70 transactions across various pharmaceutical services sub-sectors, thereby building a premier group of companies committed to advancing healthcare solutions. Water Street's strategy entails forming synergistic partnerships with leadership teams, providing the necessary industry insights and resources to achieve significant growth objectives.

Dr. Johnston's extensive experience and proven leadership in clinical research will undoubtedly enhance this mission. As he steps into his new role, he aims to collaborate closely with Water Street's team, driving innovative solutions that align with their philosophy of generating meaningful impacts on patient care and the wider healthcare ecosystem.

Looking Ahead

As the healthcare industry continues to evolve, the challenges and opportunities ahead are substantial. Water Street Healthcare Partners, underpinned by Dr. Johnston’s leadership, is well-positioned to tackle these dynamics head-on. With a dedication to patient-oriented business models and strategic investments, the firm is poised to pave the way for advancements in drug and device development, ultimately contributing to a more efficient healthcare system.

For further information about David Johnston’s role and Water Street’s initiatives, visit waterstreet.com.